DRX-065, the deuterated (R)-enantiomer of pioglitazone, as a nonalcoholic steatohepatitis (NASH) drug candidate: Preclinical and phase 1 results

Vincent Jacques

Lex Van der Ploeg

Sheila Dewitt

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com